Bio-Techne (TECH) Revenue (2009 - 2026)

Bio-Techne's Revenue history runs 18 years deep, the most recent figure standing at $311.4 million for Q1 2026.

• In Q1 2026, Revenue fell 1.51% year-over-year to $311.4 million; the TTM figure through Mar 2026 stood at $1.2 billion (changed 0.17% YoY), while the FY2025 annual figure was $1.2 billion, up 5.23% from the prior year.
• Revenue was $311.4 million for Q1 2026 at Bio-Techne, up from $295.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $317.0 million in Q2 2025 to a low of $2.0 million in Q3 2022.
• Historically, Revenue has averaged $277.7 million across 5 years, with a median of $294.1 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue tumbled 99.22% in 2022, then soared 13746.75% in 2023.
• A 5-year view of Revenue shows it stood at $271.6 million in 2022, then increased by 0.37% to $272.6 million in 2023, then advanced by 8.96% to $297.0 million in 2024, then retreated by 0.39% to $295.9 million in 2025, then rose by 5.25% to $311.4 million in 2026.
• The last three Revenue figures came in at $311.4 million (Q1 2026), $295.9 million (Q4 2025), and $286.6 million (Q3 2025), per Business Quant data.